The global multiplex biomarker imaging market size was USD 470.33 million in 2023, estimated at USD 526.30 million in 2024 and is expected to be worth around USD 1620.07 million by 2034, expanding at a CAGR of 11.90% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Multiplex Biomarker Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Multiplex Biomarker Imaging Market, by Component Type, 2024-2034
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Multiplex Biomarker Imaging Market, by Imaging Technique, 2024-2034
9.1.1. Immunohistochemistry (IHC) Assay
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Fluorescent In Situ Hybridization (FISH) Assay
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Tissue Microarray (TMA) Assay
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.1.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.1.3.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.1.4.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.2.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.2.3.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.2.4.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.2.5.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.2.6.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.3.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.3.3.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.3.4.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.3.5.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.3.6.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.4.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.4.3.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.4.4.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.4.5.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.4.6.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.5.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.5.3.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Component Type (2021-2034)
10.5.4.2. Market Revenue and Forecast, by Imaging Technique (2021-2034)
11.1. Thermo Fisher Scientific Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Merck KGaA
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. PerkinElmer Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Illumina, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Abcam plc
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Agilent Technologies, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Bio-Rad Laboratories, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Ayoxxa Biosystems GmbH
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Akoya Biosciences, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Bio-Techne Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample